[Helicobacter pylori: reasons for eradication]

Area of Science:

• Gastroenterology
• Microbiology
• Oncology

Background:

• Helicobacter pylori infection is a primary cause of peptic ulcer disease, gastric adenocarcinoma, and MALT lymphoma.
• Its role in functional dyspepsia and gastro-esophageal reflux disease is under investigation.
• The interplay between H. pylori and NSAIDs is an active area of research.

Purpose of the Study:

• To outline the established indications for H. pylori eradication therapy.
• To describe the standardized diagnostic and therapeutic approaches for H. pylori infection.
• To highlight ongoing research into H. pylori's broader roles in gastrointestinal diseases.

Main Methods:

• Review of established clinical guidelines and ongoing research.
• Standardized diagnostic protocols for H. pylori detection.
• Recommended one-week eradication regimens combining proton pump inhibitors with clarithromycin and amoxicillin or metronidazole.

Main Results:

• Established indications for eradication include peptic ulcer disease, gastric MALT lymphoma, and early gastric cancer.
• Atrophic gastritis and family history of gastric cancer are widely accepted indications.
• Standardized treatment involves a proton pump inhibitor, clarithromycin, and either amoxicillin or metronidazole for one week.

Conclusions:

• H. pylori eradication is a standardized and crucial intervention for specific gastrointestinal conditions.
• Established indications cover a range of diseases from ulcers to precancerous lesions and gastric cancer.
• Ongoing research continues to define the full spectrum of H. pylori's impact on digestive health.